An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer

Osteosarcoma Recurrent Clinical Trial

Official title:
A Multicentre, Retrospective, Observational Study to Analyse the Efficacy of High Dose Isofosfamide Administered Through Elastomer in Patients With Relapsed/ Refractory Osteosarcoma

Status Completed

Clinical Trial Summary

A multicentre, observational, retrospective study to analyse the efficacy of high dose isofosfamide thorugh elastomer in patients with relapsed/ refractory osteosarcoma

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04651569
Study type	Observational
Source	Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Contact
Status	Completed
Phase
Start date	October 2, 2020
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03628209` - Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma	Phase 1/Phase 2
Recruiting	`NCT04417062` - Olaparib With Ceralasertib in Recurrent Osteosarcoma	Phase 2
Active, not recruiting	`NCT04803877` - SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma	Phase 2
Not yet recruiting	`NCT06465199` - Difluoromethylornithine (DFMO) and AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas	Phase 1/Phase 2
Completed	`NCT04651179` - Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma